文献速递炎症性肠病消化内镜

粪便钙卫蛋白与溃疡性结肠炎病变范围相关,但仍是黏膜愈合的可靠标志物

Fecal Calprotectin Correlates With Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis.
PubMed 文献 · Am J Gastroenterol · 2025-01-30

该单中心观察性研究纳入254例溃疡性结肠炎患者共518次访视,分析粪便钙卫蛋白(FC)与黏膜炎症活动度及病变范围的关系。结果显示,内镜下活动期(MES≥2)直肠炎FC水平显著低于左半结肠炎和全结肠炎,而MES≤1时全结肠炎FC显著高于直肠炎和左半结肠炎;但FC在各病变范围内仍是黏膜愈合的可靠标志物,曲线下面积0.878至0.915,各范围间无显著差异。

要点

  • 内镜下活动期(MES≥2)直肠炎FC水平显著低于左半结肠炎和全结肠炎。
  • MES≤1时全结肠炎FC水平显著高于直肠炎和左半结肠炎。
  • FC在各病变范围内仍是黏膜愈合的可靠标志物,AUC 0.878至0.915,范围间无显著差异。

核心结论

  • FC与病变范围显著相关,但在所有病变范围内仍是黏膜愈合的可靠替代标志物。

研究设计与样本

  • 单中心观察性研究,纳入254例溃疡性结肠炎患者,共分析518次访视。
  • 黏膜炎症活动度采用Mayo内镜评分(MES)和Nancy组织学指数(NHI)评估。
  • 内镜病变范围按蒙特利尔分型分类,组织学活动性炎症(NHI≥2)范围按结直肠分布分类。
  • FC采用EliA钙卫蛋白酶荧光免疫分析法(Phadia)测定。

主要发现

  • 内镜下活动期(MES≥2)中,直肠炎FC为440(IQR 175-1,350)mg/kg,低于左半结肠炎840(IQR 298-2,011)mg/kg(P=0.048)和全结肠炎1,690(IQR 723-2,582)mg/kg(P=0.00005)。
  • MES≤1时,全结肠炎FC为85(IQR 43-350)mg/kg,高于直肠炎24(IQR 15-116)mg/kg(P=0.00032)和左半结肠炎40(IQR 15-160)mg/kg(P=0.012)。
  • FC在各病变范围内仍是黏膜愈合的可靠标志物,AUC范围0.878至0.915,各范围间无显著差异(DeLong检验,P≥0.2919)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Fecal calprotectin (FC) is a marker of mucosal inflammatory activity in ulcerative colitis (UC). FC levels may also be influenced by the extent of disease. We aimed to examine the relationships between FC, mucosal activity, and disease extent and to assess how disease extent affects the diagnostic accuracy of FC. METHODS: We conducted a single-center observational study of patients with UC. Mucosal inflammatory activity was rated by the Mayo Endoscopic Score (MES) and Nancy Histological Index (NHI). The endoscopic and histological extents of disease were categorized by the Montreal classification and colorectal distribution of histologically active inflammation (NHI ≥ 2), respectively. FC was measured by EliA Calprotectin Enzyme fluoroimmunoassay (Phadia). RESULTS: A total of 518 visits by 254 patients were analyzed. In endoscopically active UC (MES ≥ 2), FC levels were significantly lower in proctitis (440 [interquartile range (IQR) 175-1,350] mg/kg) as compared with left-sided colitis (840 [IQR 298-2,011] mg/kg, P = 0.048) or pancolitis (1,690 [IQR 723-2,582] mg/kg, P = 0.00005). In MES ≤1, FC levels were significantly higher in pancolitis (85 [IQR 43-350] mg/kg) as compared with proctitis (24 [IQR 15-116] mg/kg, P = 0.00032) or left-sided colitis (40 [IQR 15-160] mg/kg, P = 0.012). However, FC remained a reliable marker of mucosal healing across all disease extents, with area under the receiver-operating characteristic curve ranging from 0.878 to 0.915, and no significant differences between the extent categories (DeLong test, P ≥ 0.2919). DISCUSSION: FC showed a significant association with disease extent yet remained a reliable surrogate marker for mucosal healing across all disease extents.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Steinsbø Ø, Aasprong OG, Aabakken L, et al. Fecal Calprotectin Correlates With Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis. Am J Gastroenterol. 2025. PMID: 39882797. doi:10.14309/ajg.0000000000003339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。